HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

aldesleukin (Proleukin)

a recombinant human IL-2, marketed for the treatment of metastatic renal cell carcinoma; BAY 50-4798 is a variant
Also Known As:
Proleukin; Asofarma brand of aldesleukin; BAY 50-4798; CSL brand of aldesleukin; Chiron brand of aldesleukin; 2-133-Interleukin 2 (human reduced), 125-L-serine-
Networked: 37 relevant articles (3 outcomes, 11 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Ernstoff, Marc S: 3 articles (02/2015 - 06/2007)
2. Atkins, Michael B: 2 articles (02/2015 - 06/2007)
3. Clark, Joseph I: 2 articles (02/2015 - 06/2007)
4. McDermott, David F: 2 articles (02/2015 - 08/2009)
5. Dutcher, Janice P: 2 articles (02/2015 - 06/2007)
6. Cusi, Maria Grazia: 2 articles (06/2012 - 07/2008)
7. Correale, Pierpaolo: 2 articles (06/2012 - 07/2008)
8. Tagliaferri, Pierosandro: 2 articles (06/2012 - 07/2008)
9. Tassone, Pierfrancesco: 2 articles (06/2012 - 07/2008)
10. Cassell, Delanie J: 2 articles (02/2008 - 03/2006)

Related Diseases

1. Renal Cell Carcinoma (Grawitz Tumor)
2. Neoplasms (Cancer)
3. HIV Infections (HIV Infection)
4. Melanoma (Melanoma, Malignant)
5. Colonic Neoplasms (Colon Cancer)

Related Drugs and Biologics

1. Interleukin-2 (IL2)
2. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
3. chiron
4. gemcitabine
5. Hormones
6. Fluorouracil (Carac)
7. vitespin
8. Esapent
9. cetuximab (Erbitux)
10. molgramostim

Related Therapies and Procedures

1. Highly Active Antiretroviral Therapy (HAART)
2. Nephrectomy
3. Combination Drug Therapy (Combination Chemotherapy)
4. Subcutaneous Injections
5. Injections